INTRODUCTION: Sickle cell disease (SCD)-associated priapism is characterized by endothelial nitric oxide synthase (eNOS) dysfunction in the penis. However, the mechanism of decreased eNOS function/activation in the penis in association with SCD is not known. AIMS: Our hypothesis in the present study was that eNOS is functionally inactivated in the SCD penis in association with impairments in eNOS post-translational phosphorylation and the enzyme's interactions with its regulatory proteins. METHODS: Sickle cell transgenic (sickle) mice were used as an animal model of SCD. Wild-type (WT) mice served as controls. Penes were excised at baseline for molecular studies. eNOS phosphorylation on Ser-1177 (positive regulatory site) and Thr-495 (negative regulatory site), total eNOS, and phosphorylated AKT (upstream mediator of eNOS phosphorylation on Ser-1177) expressions, and eNOS interactions with heat-shock protein 90 (HSP90) and caveolin-1 were measured by Western blot. Constitutive NOS catalytic activity was measured by conversion of L-[14C]arginine-to-L-[14C]citrulline in the presence of calcium. MAIN OUTCOME MEASURES: Molecular mechanisms of eNOS dysfunction in the sickle mouse penis. RESULTS: eNOS phosphorylated on Ser-1177, an active portion of eNOS, was decreased in the sickle mouse penis compared with WT penis. eNOS interaction with its positive protein regulator HSP90, but not with its negative protein regulator caveolin-1, and phosphorylated AKT expression, as well as constitutive NOS activity, were also decreased in the sickle mouse penis compared with WT penis. eNOS phosphorylated on Thr-495, total eNOS, HSP90, and caveolin-1 protein expressions in the penis were not affected by SCD. CONCLUSIONS: These findings provide a molecular basis for chronically reduced eNOS function in the penis by SCD, which involves decreased eNOS phosphorylation on Ser-1177 and decreased eNOS-HSP90 interaction.
INTRODUCTION:Sickle cell disease (SCD)-associated priapism is characterized by endothelial nitric oxide synthase (eNOS) dysfunction in the penis. However, the mechanism of decreased eNOS function/activation in the penis in association with SCD is not known. AIMS: Our hypothesis in the present study was that eNOS is functionally inactivated in the SCD penis in association with impairments in eNOS post-translational phosphorylation and the enzyme's interactions with its regulatory proteins. METHODS: Sickle cell transgenic (sickle) mice were used as an animal model of SCD. Wild-type (WT) mice served as controls. Penes were excised at baseline for molecular studies. eNOS phosphorylation on Ser-1177 (positive regulatory site) and Thr-495 (negative regulatory site), total eNOS, and phosphorylated AKT (upstream mediator of eNOS phosphorylation on Ser-1177) expressions, and eNOS interactions with heat-shock protein 90 (HSP90) and caveolin-1 were measured by Western blot. Constitutive NOS catalytic activity was measured by conversion of L-[14C]arginine-to-L-[14C]citrulline in the presence of calcium. MAIN OUTCOME MEASURES: Molecular mechanisms of eNOS dysfunction in the sickle mouse penis. RESULTS:eNOS phosphorylated on Ser-1177, an active portion of eNOS, was decreased in the sickle mouse penis compared with WT penis. eNOS interaction with its positive protein regulator HSP90, but not with its negative protein regulator caveolin-1, and phosphorylated AKT expression, as well as constitutive NOS activity, were also decreased in the sickle mouse penis compared with WT penis. eNOS phosphorylated on Thr-495, total eNOS, HSP90, and caveolin-1 protein expressions in the penis were not affected by SCD. CONCLUSIONS: These findings provide a molecular basis for chronically reduced eNOS function in the penis by SCD, which involves decreased eNOS phosphorylation on Ser-1177 and decreased eNOS-HSP90 interaction.
Authors: K A Pritchard; A W Ackerman; E R Gross; D W Stepp; Y Shi; J T Fontana; J E Baker; W C Sessa Journal: J Biol Chem Date: 2001-03-16 Impact factor: 5.157
Authors: Biljana Musicki; Tongyun Liu; Travis D Strong; Gwen A Lagoda; Trinity J Bivalacqua; Arthur L Burnett Journal: J Sex Med Date: 2010-03-11 Impact factor: 3.802
Authors: Jingsong Ou; Jason T Fontana; Zhijun Ou; Deron W Jones; Allan W Ackerman; Keith T Oldham; Jun Yu; William C Sessa; Kirkwood A Pritchard Journal: Am J Physiol Heart Circ Physiol Date: 2003-10-09 Impact factor: 4.733
Authors: Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia Journal: J Clin Invest Date: 2008-04 Impact factor: 14.808
Authors: Gwen Lagoda; Sena F Sezen; K Joseph Hurt; Marcelo R Cabrini; Dillip K Mohanty; Arthur L Burnett Journal: FASEB J Date: 2013-09-27 Impact factor: 5.191
Authors: Nikolai A Sopko; Hotaka Matsui; Johanna L Hannan; Dan Berkowitz; Hunter C Champion; Lewis L Hsu; Biljana Musicki; Arthur L Burnett; Trinity J Bivalacqua Journal: J Sex Med Date: 2015-09-07 Impact factor: 3.802
Authors: Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Dan E Berkowitz; Hunter C Champion; Arthur L Burnett Journal: PLoS One Date: 2013-07-02 Impact factor: 3.240